We examined rapid ventricular cardiac pacing as a means of inducing heart failure in the dog to establish the sequence and nature of physiologic compensation in this preparation. Seven animals paced at 250 beats/min for 3 weeks (VP8 group) showed an increase in cardiac size from 78.5 + 9.5(SD) to 105.8 ± 13.0 cm2, a reduction in mean arterial pressure from 149 ± 7 to 130 ± 21 mm Hg, a fall in cardiac index from 196 ± 57 to 125 ± 37 ml/kg/min, and an increase in left ventricular filling pressure from 6 + 5 to 22 + 9 mm Hg and in right atrial pressure from 2 ± 2 to 5 ± 3 mm Hg. An additional series of six animals (VP2 group) was paced until a clear biologic end point for heart failure was reached (average 5.3 + 1.9 weeks) and they showed similar but more advanced changes compared with the VP8 group. The changes in cardiac size and hemodynamics in the VP1 and VP2 groups were significantly different from those in parallel studies of 10 sham-operated animals. Plasma norepinephrine and renin activity were unchanged in sham-operated animals, whereas in the VP1 group, plasma norepinephrine rose from 338 + 118 to 764 ± 567 pg/ml (p < .05), but plasma renin activity did not change. In the VP2 group norepinephrine rose from 471 ± 285 to 999 ± 425 pg/ml (p < .025) and plasma renin rose from 2.1 1.5 to 8.0 ± 7.1 ng/ml/hr (p < .05). There was an excellent correlation between plasma norepinephrine and renin activity before the animals were killed in both the VP1 and VP2 groups (r = .88, p < .001). No change was evident in atrial natriuretic factor content, as determined by bioassay, in sham-operated or VP1 group animals. However, there was a significant reduction in atrial natriuretic activity from the right atrium that was inversely correlated with the level of right atrial pressure in the VP2 group.
comitant pharmacologic therapy and the uncertainty associated with identifying when heart failure begins. Previous experimental preparations of heart failure have been ones of major surgical trauma,6 myocardial ischemia,7 and pharmacologic or toxic depression of cardiac function.8 However, all of these interventions may directly affect neurohumoral factors independent of the primary influence of heart failure.
Accordingly, the development of other animal preparations of heart failure is of high priority. The requirements for an ideal preparation include ready availability and reasonable amenability to measurements (including those characterizing hemodynamic performance). There should be no need to induce trauma that might perturb various compensatory mechanisms, and the preparation should yield reasonably predictable and quantifiable results so as to facilitate the planning of investigative studies.
In the current investigation we have evaluated the effects of rapid cardiac pacing, a method that was first reported to produce experimental heart failure in 19629 and was further modified in 1982.10 Our objectives were (1) to characterize the clinical, radiographic, and hemodynamic profile of heart failure as induced by rapid ventricular pacing in a canine preparation, (2) to establish the sequence and nature of the neurohumoral compensations for congestive heart failure in this preparation as assessed by plasma norepinephrine, renin, and atrial tissue natriuretic factor content.
Methods
Fixed end point study. Fifteen mongrel dogs weighing 18 to 25 kg were conditioned for 10 days and acclimated to holding facilities for 5 days before the study. Throughout the study, the animals were supplied with dog chow and water ad libitum. For the initial hemodynamic study surgical anesthesia was induced with sodium thiopental (19.77 + 1 .72 mg/kg) and maintained with sodium thiopental (6.48 + 3.03 mg/kg/hr) and morphine sulfate (253 ± 16 pg/kg/hr). Under direct vision a 20-gauge plastic cannula was inserted into the right femoral artery of each dog and a No. 7F Swan-Ganz flow-directed thermodilution catheter was passed from the femoral vein to the pulmonary artery. A small subcutaneous pocket was created anterior to the first rib for insertion of the pacemaker generator. A unipolar pacemaker lead (Medtronic 6907R) was placed in the right ventricular apex under fluoroscopic visualization via the right external jugular vein. Five animals were randomly selected to undergo sham operation (S, group) and in 10 animals (VP1 group) custom SX-5985 (Medtronic) pulse generators set to deliver 250 beats/min asynchronously were implanted. After hemodynamic evaluation the monitoring catheters were removed, the incisions were closed, and the animals were allowed to recover in their cages. The animals were kept under daily observation and a formal clinical evaluation was conducted twice weekly.
Venous blood samples for neurohumoral determinations were obtained from conscious animals before the initial implantation of the pacemaker and thereafter at weekly intervals for 3 weeks. Chest roentgenograms were obtained immediately after the first surgical procedure and thereafter at weekly intervals for control purposes and to confirm location of the lead tip. At the end of 3 weeks, a repeat hemodynamic study was performed and each animal was killed so a postmortem examination could be done.
Clinical end point study. Because the clinical and radiographic manifestations of heart failure were variable and in some instances incomplete during our initial 3 week fixed-end point study, we studied an additional series of eight animals (VP2 group) in which our goal was to produce unequivocal manifestations of advanced heart failure as defined by a 25% or greater increase in cardiac size and/or a 10% or greater increase in body weight. These animals were instrumented, paced, and handled in a fashion identical to those in the VPI group except that the hemodynamic restudy was performed when the criteria listed above had been fulfilled or a maximum of 8 weeks on pacing had elapsed. Restudy time for animals in the VP, group was 5.3 ± 1.9(SD) weeks. Because on restudy of the paced animals in the first series thiopental anesthesia was associated with circulatory collapse and death of two animals before instrumentation to determine hemodynamics, restudy in the VP2 group was conducted with local anesthesia with lidocaine (without epinephrine) and intravenous morphine sulfate (285 + 51 ,ug/kg/hr). Accordingly, an additional series of five animals (S2) was randomly selected to undergo sham operations. These animals were observed for 8 weeks and they received anesthesia identical to that given to the VP2 group, i.e.. thiopental and morphine during the initial hemodynamic study and local anesthesia and morphine alone (282 + 101 ,ug/kg/hr) during restudy.
Hemodynamic evaluation. The right atrial pressure; pulmonary arterial systolic, diastolic, and mean pressures. pulmonary capillary wedge pressure measured by balloon occlusion; systemic arterial systolic, diastolic, and mean (MAP) pressures;
and electrocardiogram (heart rate [HR]) were recorded on an Electronics for Medicine physiologic recorder. When a satisfactory pulmonary capillary wedge pressure tracing could not be obtained, pulmonary arterial diastolic pressure was used and these data are tabulated as left ventricular filling pressure (LVFP). Cardiac output (CO) was determined at least in duplicate by the thermodilution technique with the use of 5 ml of icecold 5% dextrose in water injected into the right atrium; subsequent thermodilution curves were integrated by an Edwards Cardiac Output computer. 11 Stroke volume (SV; ml/heart) was calculated as CO/HR. Total peripheral resistance (TPR; units) was calculated as MAP/Cl x 100, where CI = cardiac index (ml/kg/min).
Initially, two sets of control hemodynamic measurements were recorded at least 30 min apart to ensure a reproducible baseline. After initiation of right ventricular pacing, hemodynamic variables were monitored continuously until values were stable (usually within 5 min), at which time repeat determination of cardiac output was performed. At the conclusion of longterm pacing, a second hemodynamic evaluation was performed in a fashion similar to the initial one, with duplicate hemodynamic measurements taken at least 30 min apart to confirm a hemodynamic steady state. The pulse generator was then reprogrammed (9701E Programmer Medtronic) into a demand mode so as to allow resumption of sinus rhythm and hemodynamic measurements were recorded within 10 min after they had stabilized.
Clinical and pathologic evaluation. The clinical evaluation included observations of heart rate, respiratory rate, and body weight, as well as a search for peripheral edema and ascites. Electrocardiographic rhythm strips were recorded weekly to confirm pacemaker capture. Chest roentgenograms were obtained in dogs in the right lateral recumbent position and care was taken to ensure identical positioning, milliampere and kilovolt settings, and central beam distance and orientation during serial examinations. Reproducibility was further ensured by marking exterior skin points to indicate positioning of the central beam. The x-ray films obtained were evaluated qualitatively for vascular congestion, pleural effusions, and edema. Quantification of cardiomegaly was performed by planimetry of each cardiac silhouette and the results were expressed in square centimeters.
A postmortem cardiac examination was conducted of each animal and included measurement of heart weight. Free wall thicknesses of the right and left ventricles were measured in each heart at a point on the free ventricular wall halfway from the atrioventricular valvular ring to the apex. Fresh left ventricular tissue from the same area was fixed in formalin and paraffin sections were prepared. Multiple 5 gm sections of left ventricular free wall were stained with hematoxylin and eosin and examined by light microscopy. The extent of various histologic changes were subjectively assessed as mild, moderate, or severe by one observer in a blinded fashion. Tissue was also taken from the same region of free left ventricular wall for quantitative estimation of norepinephrine. For this purpose, each sample was rapidly dissected, flash frozen in liquid N2, and stored at -800 C. Precision weighed tissue was then homogenized and norepinephrine was extracted in a fixed volume of iced perchloric acid: reduced glutathione (0.4M:5 mM) buffer. Ho-mogenates were then centrifuged and the supematant was assayed by the method described below. Sample results were corrected for dilution and normalized for wet weight.
Qualitative assessment of ascites was performed in animals in the S, and VP, groups and quantitative measurements of ascites performed in animals in the S2 and VP2 groups. Neurohumoral evaluation. Estimation of concentrations of norepinephrine in plasma and left ventricular tissue homogenate was performed by radionenzymatic assay (Cat-a-kit, Upjohn Laboratories, Kalamazoo, MI). This assay has a sensitivity of 2.4 pg and a precision of 4.2% and 7.5%, respectively, within and between samples. Plasma renin activity was measured by radioimmunoassay (Renak Kit, Roche Laboratories, Nutley, NJ). This assay has a sensitivity of 3 pg AI and a 7.3% and 6.9% precision, respectively, within and between samples.
Natriuretic factor was extracted from freshly dissected atria that were immediately rinsed in ice-cold phosphate-buffered saline. While immersed in this solution, the right and left atria and interatrial septum were dissected. Each of these samples were then weighed and homogenized in a Polytron in 10 volumes of a cold extractant mixture containing I.ON HCl/l% NaCl/l .OM acetic acid. The homogenate was left to stand for 30 min on ice and was then centrifuged at 15.000 g for 30 min at 5 volumes of the extractant and centrifuged as above. The supernatants were combined and passed through prewetted Sep-Pak cartridges (Waters Scientific). One cartridge was used for every 40 ml of homogenate. The cartridges were washed with 20 ml of 0.1% trifluoracetic acid (TFA) and eluted with 3.0 ml of 80% acetonitrile in 0.1% TFA. The eluates were frozen, freezedried, and kept at -20% C until they were bioassayed for natruiretic activity as follows. 12 Male Spraeue-Dawley rats (250 to 300 g) were anesthetized with Inactin (BYK Gulden Konstanz, West Germany, 10 mg/100 g body weight ip) and a tracheotomy performed. Arterial blood pressure was continuously monitored through a femoral artery cannula and infusions were made through a femoral vein cannula. Urine was collected through a bladder catheter. Temperature was kept at 38 + 0.50 C with a warming pad and lamp, both of which were connected to a control unit that was in tum connected to a rectal probe.
Immediately after surgery, the animals wvere primed (Syringe Infusion Pump, model 2620, Harvard Apparatus) with 1.2 ml of Ringer's solution in meq/liter: (130 NaCI. 5 KCl, 5.3 CaCl2, 2
NaHCO3 over 20 min, followed by a constant infusion of the same solution throughout the experiment at a rate of 1.2 ml/hr. After a 20 min equilibration period, urine was collected in preweighed vials for a 20 min period (control period), followed by injection of the test sample (0.2 ml) and another 20 min period during which urine was collected (test period). Each sample was assayed in a different rat. Rats that had a urine output of more than 100 ,uL during the control period were considered to be in spontaneous diuresis and were discarded. Urinary sodium and potassium concentrations were measured by flame photometry and chloride was measured by electrometric titration.
Homogenate aliquots (0.5 ml) were digested in 5 ml of 0. 1 NaOH. Parallel digestions were carried okit of standards made from a serum pool that in tum had its protein concentration measured against standards made from bovine serum albumin.
Protein concentration was measured colorimetrically with a Bio-Rad protein kit (Bio-Rad Laboratories).
Statistical analysis. All summary statistics are presented as the mean + SD. Within-group comparisons were made by analysis of variance with Tukey's method to identify sources of statistical differences. Comparisons of results in S, and VP, and S2 and VP2 groups were performed with the unpaired Student t test.13 Correlations were performed by linear regression analysis.
Results
Clinical and radiographic data are listed in table 1. Control heart rate, respiratory rate, and body weight were obtained in dogs in the conscious state immediately before general anaesthesia was administered and the pacemaker was inserted, whereas x-ray data were obtained after pacemaker insertion.
Heart rate did not change in either the S, or S2 group during the study period. As expected, paced animals maintained a rapid ventricular rate of 250 beats/min; in two animals intermittent pacing was evident only at 1 week. Respiratory rate was unchanged in the shamoperated animals, whereas it increased markedly from control in both paced groups, although this increase was statistically significant only in the VP2 group. There was no significant change in weight in shamoperated animals or in those in the VP1 group, but there was a significant increment in weight in the VP2 group at the time of the study end point. Four animals, two from the VPI and two from the VP2 group, experienced sudden and unexpected death between 2 and 5 days after insertion of the pacemaker and were excluded from analysis. Three other dogs, two from the VPI and one from the VP2 group, died during or just before repeat hemodynamic study, accounting for the differences in sample sizes for hemodynamic and other observations.
There was a slight but insignificant rise in planimetered cardiac area in the sham-operated animals at week 1, but no overall change throughout the study period. By contrast, there was a 31% increase in area in the VP1 group at 3 weeks. This change became statistically significant after the second week and also represented a significant increase over the value for the S, group at 3 weeks. A similar pattern of increasing cardiac size throughout the period of cardiac pacing was seen in the VP2 group; by the end of the study, there was a 46% increase in size and the change from control dimensions became significant at 1 week of pacing. Heart size in the VP2 group was significantly increased compared with that in the S2 group at the end of the study.
In figure 1 , a representative series of films is shown from an experimental animal in the VP, group. In comparison with the control film (figure 1, A), there was progressive cardiomegaly over the subsequent 3 weeks of pacing associated with increased prominence of the pulmonary vasculature, pulmonary congestion, air alveolograms, peribronchial cuffing, and pleural effusions. All but one animal in the VP1 group had increased pulmonary vascularity and four had pleural Vol. 74, No. 5, November 1986 effusions. All of the animals in the VP, group had increased pulmonary vascularity and five of the six had associated pleural effusions. The hemodynamic results obtained during anesthesia are shown in table 2. For sham-operated animals they represent data from the initial and repeat study after 3 (Si) or 8 weeks (S2) of normal sinus rhythm. For paced animals they represent initial data during sinus rhythm and within 3 to 5 min of commencement of rapid ventricular pacing during the first study. At the 3 week repeat study in the VP1 group, hemodynamic measurements were recorded during pacing and during the 10 min immediately after cessation of pacing. At the conclusion of the study, i.e., at 5.3 + 1.9 weeks, data from the VP2 group were accumulated in a manner similar to the procedure used for the VP1 group.
In the S, group, there was no significant difference from initial to repeat study with respect to values for any of the hemodynamic variables, i.e., heart rate, mean arterial pressure, cardiac index, stroke volume, LVFP, mean pulmonary arterial pressure, right atrial pressure, or total peripheral resistance. In the S2 group, the repeat study highlighted the effects of the different types of anesthesia used. Thus, morphine sedation in our sham-operated animals, as compared with pento-thal/morphine anesthesia, was associated with a much slower heart rate, a lower cardiac index and higher stroke volume, LVFP, mean pulmonary arterial pressure, and right atrial pressure. In the VP1 and VP2 groups, mean arterial pressure fell abruptly with the onset of pacing and was significantly different from control at the time of restudy as well as after resumption of sinus rhythm. It should be noted, however, that mean arterial pressure during repeat normal sinus rhythm in VP1 and VP2 groups was no different than that in Si and S2. Cardiac index and stroke volume fell sharply at the onset of pacing in both groups and this depression became more pronounced at the time of restudy. Although cardiac index increased after resumption of sinus rhythm, it remained significantly depressed as compared with control values in the SI and S, groups. LVFP rose initially with the onset of pacing and was dramatically elevated at the time of repeat study; these abnormalities persisted after return to sinus rhythm. Mean pulmonary and right atrial pressure in the VP1 and VP2 groups were elevated at the time of repeat study, but after resumption of sinus rhythm, these abnormalities remained significantly different from control and from results in sham-operated dogs only in the VP, group. It should be noted that mean arterial pressure and cardiac index were lower and right atrial pressure was substantially higher in the VP2 group than in the VP] animals after resumption of sinus rhythm. The similarities in stroke volume and differences in cardiac index in the VPI and VP2 groups resulted from the differing heart rates during sinus rhythm at the time of restudy and reflects the use of morphine alone in the VP2 group. Although total peripheral resistance rose significantly during pacing in both series, it returned toward the control level during sinus rhythm.
Data on plasma norepinephrine and renin activity are shown in figure 2. There were no significant changes in either norepinephrine or renin in the sham- week ventricular pacing; C, after 2 weeks of ventricular pacing; D, immediately before hemodynamic evaluation after 3 weeks of rapid ventricular pacing. All radiographs were exposed at 40 kV, 3 mAs with the source 32 inches from the film. operated animals. In both paced groups plasma norepinephrine rose progressively throughout the study, reaching statistical significance by the first week in the VP1 and by the third week in the VP2 group. No changes were evident in plasma renin during the first 2 weeks of pacing in either experimental group. An abrupt rise in renin was seen in both paced groups at 3 weeks, but it was statistically significant only in the VP2 group. Ascites were not found in sham-operated animals at postmortem examination. However, they All data represent mean _ SD for Sl, n = 5; VP1, n = 5; S2, n = 5; VP2, n = 5 unless otherwise indicated in parentheses.
At repeat study during normal sinus rhythm; CI, SV, LVFP, MPA, and TPR in VP1 and S, groups were significantly different TTT.T beside the corresponding concentration of norepinephrine in the left ventricular free wall tissue. The relationship between the tissue and plasma concentrations in the S, group indicates a tissue norepinephrine content of 795 ng/g as comparaed with a plasma concentration of 279 pg/ml. Similarly, in the S2 group, tissue content of norepinephrine was 817 ng/g as compared with a plasma concentration of 237 pg/ml. The converse was true in both groups of paced animals, in which there was marked depression of tissue concentrations of norepinephrine that was inversely correlated with the striking elevation in plasma norepinephrine previously described (r = .63, p < .01). Both plasma and tissue norepinephrine in the paced animals were , * significantly different when compared with those in the sham-operated groups.
In table 3 , the results of the bioassay of atrial extract are shown. The data are presented as differences between the control and test periods with respect to urinary electrolytes and volumes, i.e., differences after the injection of atrial extract. There were no differences evident between animals in the SI and VP1 groups. However, right atrial extract from VP2 animals induced significantly less urinary potassium, chloride, and volume than that from sham-operated animals. S, and VP1 and at the end of study and VP2 were significant (p < .05 and p < .01, respectively, unpaired t). B, Plasma renin activity in S , and S2, VP1 and VP2 groups at control (0) and 1, 2, and 3 weeks thereafter. "e" indicates conclusion of experiment in S2 and VP2 animals. Values are mean ± SD. * p < .05; + p < .01, for comparison with control by analysis of variance. The difference between S2 and VP2 at the end of study was significant (p < .025, unpaired t).
were evident in one and marked in two other animals in the VP1 group. Quantitative estimates of ascites at postmortem examination in VP2 animals yielded a value of 2.9 1.8 liters, which correlated well with final plasma renin values in these animals (r = .78, p < .025). When the relationship between plasma norepinephrine and renin was examined before the animals in the VP1 and VP2 groups were killed ( figure 3) , there was a good correlation (r = .88, p < .001). In figure 4 , the final plasma norepinephrine concentration data for the four groups of animals are replotted There was also a trend toward reduced urinary excretion of sodium in response to right atrial extract from the VP2 groups, but this change was not statistically significant. A similar but insignificant trend was evident for septal atrial extract and no differences were observed between effects of left atrial extract from the VP2 group and that from sham-operated dogs. When the right atrial pressure of animals in the VP, group was correlated with the effects of right atrial extract on urinary sodium, chloride, and volume, there was an inverse relationship (r = -.90, p < .025; r = .89, p < .025, and r = .82, p < .05, respectively). Postmortem data. Cardiac weights in the sham-operated population were as folows: In the S1 group total cardiac weight was 166.3 + 19.3 g, cardiac weight normalized for body weight was 8.19 + 0.86 g/kg, and right and left ventricular free wall thicknesses were 5.0 ± 1.0 and 11.6 1.6 mm, respectively. In the S, group, total cardiac weight was 174.5 ± 18.6 g, normalized weight was 7.91 ± 1 .2 g/kg, and right and left ventricular free wall thicknesses were 5.9 + 0.8 and 11.2 ± 1.0 mm, respectively. In the VPI group, gross and normalized cardiac weights were 179 + 25.9 and 8.29 ± 0.59 g, respectively, and right and left ventricular wall thicknesses were 5.1 t 0.7 and 12.8 ± 2.3 mm. In the VP, group, gross and normalized weights were 186.4 ± 43.2 and 7.45 + 1.32 g, and right and left ventricular wall thicknesses were 5.5 + 0.9 and 11.3 ± 2.9 mm. Histologic examination of the left ventricular free wall revealed changes characterized by interstitial edema, vascular congestion, and focal necrotic and eosinophilic myofibers in paced animals. In addition, there were focal contraction bands in four animals and endocardial thickening in three. There was no evidence of edema, congestion, or hemorrhage in the hearts of the sham-operated animals.
Discussion
Our findings indicate that long-terrm rapid ventricular pacing in the mongrel dog is an effective method for creating congestive heart failure. The cliniical manifestations are characterized by tachypnea, weight gain, and ascites. Weight gain in these animals must be assessed with the knowledge that there is likely a loss of lean body mass. Coleman et al.14 used a similar method of producing heart failure and noted an average 1.4 kg weight loss in animals despite the development of ascites. In conjunction with our clinical findings, there was clear evidence of increased cardiac size and pulmonary congestion radiographically that became progresively more severe over the period of rapid cardiac pacing. Postmortem examination confirmed that this increase in size was related to cardiac dilatation without absolute wall thickening. The immediate hemodynamic effects of rapid ventricular pacing emphasize the dramatic impact of this intervention. There were major reductions in cardiac index and stroke volume associated with a rise in both left-and right-sided filling pressures. After continuation of pacing for 3 weeks or until severe heart failure developed, the hemodynamic alterations became more marked. The small declines in LVFP, mean pulmonary arterial pressure, and right atrial pressure in the VP1 group after restoration of sinus rhythm suggests that incomplete relaxation during rapid cardiac pacing may have contributed a minor amount to the elevation of these values. Similar declines were not evident in the VP2 group, however, indicating that the elevated filling pressures were not artifactually generated by rapid heart rate.
As may be seen from table 2, changes from values for sham-operated dogs in heart rate, stroke volume, LVFP, mean pulmonary pressure, and right atrial pressure were greater in the VP2, than the VP1 group. These changes in conjunction with greater weight gain and increasing cardiac size highlight the more advanced heart failure present in the VP2 group.
The usefulness of this preparation is corroborated by the reproducibility of the clinical, radiographic, and neurohumoral data from the sham-operated animals. In the S, group, when identical anesthesia techniques were used the hemodynamic findings were reproducible and in agreement with our previous findings. 15 The utility of the preparation may be limited, however, by the absence of a steady-state condition once pacing is discontinued. It should be noted that only data obtained during pacing and in the immediate postpacing period are reported here, and therefore persistence of chronic congestive heart failure in the absence of rapid ventricular pacing has not been documented.
The mechanism whereby rapid ventricular pacing produces heart failure is unclear, but several factors may be operative. The abrupt fall in stroke volume produced at the outset by rapid ventricular pacing would stimulate cardiac dilatation through the Frank-Starling mechanism so as to preserve forward flow. The sustained increase in minute work of the heart produced by rapid cardiac pacing would increase myocardial oxygen consumption, exhausting glycogen and other cardiac energy stores. The reduction of blood pressure and elevation of LVFP coupled with an abbreviated diastolic filling time would reduce coronary perfusion, further accentuating the unfavourable balance between oxygen supply and demand. The reason for the four sudden and unexpected deaths in our experimental groups is uncertain, but may have been linked Vol. 74, No. 5, November 1986 to the occurrence of ventricular arrhythmias in the poorly perfused myocardium.
Our study is limited by the absence of direct measures of left ventricular contractility and in their absence one might ask whether the central and peripheral circulatory congestion observed could be related to fluid retention alone and not to a manifestation of genuine cardiac failure. We believe this is unlikely for the following reasons. (1) Previous studies by Coleman et al.14 using an identical preparation of heart failure and conducted 24 hr after cessation of pacing indicate reduction in both the intrinsic velocity of contraction and development of isovolumetric tension in the left ventricle in association with decreases in total myocardial levels of creatinine and concentrations of high-energy phosphate, (2) Subsequent preliminary studies of the preparation in our laboratory have shown depressed left ventricular function after. cessation of pacing as compared with control function by two-dimensional echocardiography.'6 (3) There was marked depression of left ventricular concentrations of norepinephrine in animals in the VP groups, a finding previously noted in experimental and clinical heart failure and associated with impaired contractility. (4) Chidsey et al."7 have shown that cardiac norepinephrine stores are normal in the absence of heart failure when fluid overload is produced by inferior vena caval ligation, with subsequent elevation of venous pressure and increased aldosterone production. (5) Although the increase in plasma renin activity in our study was temporally related to the period of rapid accumulation of ascitic fluid and weight gain, it lagged temporally behind the major increase in cardiac size, suggesting that this neurohumoral axis postdated and did not precede myocardial dysfunction.
We found a progressive rise in plasma norepinephrine that proved to be inversely related to the left ventricular concentration of norepinephrine in the VPI and VP2 groups at the time of postmortem examination.
The values for tissue norepinephrine we observed correspond well with those previously found in other dog preparations of heart failure and those found in human heart failure. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] In contrast to norepinephrine, plasma renin remained near normal during the early phase of ventricular pacing but increased dramatically in VP2 animals during the final portion of the experimental period when it appeared related to a rapid accumulation of ascitic fluid and weight gain. Our findings are in contrast to those of Riegger and Liebau,10 who studied ventricular pacing in young beagles and found a gradual increase in renin that occurred simultaneously with the increase in plasma norepinephrine: the basis for the disparity between their studies and our own are unclear but could relate to species differences. 10 Our results show that heart failure in the mongrel dog is first associated with activation of the sympathetic nervous system. The relative contributions of renal hypoperfusion as opposed to catecholamine release in stimulating renin secretion in this setting remains to be determined. Previous studies of experimental heart failure have not evaluated the relationship between plasma norepinephrine and renin. The excellent correlation in our study between plasma norepinephrine and renin at the time heart failure was well developed raises the possibility of a causal interaction between these two separate neurohumoral axes.
Although there was no change in atrial natriuretic activity in the animals in the VP1 group, there was evidence of reduced activity in the right atrial extract of VP2 animals, suggesting a potential role for this hormone in heart failure. Animals in the VP, group animals had more advanced heart failure, as evidenced by a greater weight gain and more pronounced cardiac dilatation and pulmonary congestion. Of particular interest was the finding that the depletion of atrial natriuretic factor was primarily confined to the right atrium. The reason for this is unclear, but if chronic pressure elevation is a stimulus for release of atrial natriuretic factor, it is noteworthy that the right atrial pressure was highest in the VP, group and correlated inversely with atrial natriuretic activity. The reasons for the lack of depletion of atrial natriuretic factor from the left atrium despite commensurate increments in LVFP are unclear. Further studies are required, together with a more specific radioimmunoassay for ineasurement of plasma atrial natriuretic factor, so that the role of this substance in the genesis and maintenance of congestive heart failure may be better defined. Neither plasma aldosterone nor antidiuretic hormone were measured in our studies and both inay be operative in the neurohumoral response to congestive cardiac failure.
In conclusion, we have shown that rapid ventricular pacing is an effective means of inducing heart failure in a canine preparation. This experimental preparation should permit further studies concerning the pathogenesis and therapy of heart failure. In the current report we have provided evidence to support the concept that the sympathetic nervous system is activated before the renin-angiotensin system and that profound congestive cardiac failure is associated with depletion of atrial natriuretic factor. It is a pleasure to acknowledge the advice of K. Mackie, M.D., in the radiographic measurements, the capable technical assistance of Kenneth Green, Susan Kobus, Ann Zamora, and Thomas Abbott, the secretarial assistance of Jeanine MacRow and Maureen McCleiiaghan, and the generous support of Medtronic Limited of Canada in supplying pacemaker electrodes and batteries.
